Banque Cantonale Vaudoise Trims Position in Colgate-Palmolive (NYSE:CL)

Banque Cantonale Vaudoise reduced its position in Colgate-Palmolive (NYSE:CL) by 13.8% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 30,655 shares of the company’s stock after selling 4,924 shares during the period. Banque Cantonale Vaudoise’s holdings in Colgate-Palmolive were worth $3,182,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. E Fund Management Hong Kong Co. Ltd. acquired a new position in Colgate-Palmolive in the second quarter valued at $25,000. Continuum Advisory LLC lifted its holdings in shares of Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter worth approximately $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive in the third quarter valued at approximately $53,000. Finally, Gradient Investments LLC increased its position in Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after purchasing an additional 400 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently issued reports on CL. UBS Group boosted their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. Finally, Jefferies Financial Group downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $93.61 on Wednesday. The firm has a fifty day moving average of $98.80 and a two-hundred day moving average of $98.56. The firm has a market cap of $76.48 billion, a P/E ratio of 26.82, a P/E/G ratio of 3.34 and a beta of 0.42. Colgate-Palmolive has a 1-year low of $75.17 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.14%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s payout ratio is currently 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.37% of the stock is currently owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.